| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.09 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.09 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |